Contact
Please use this form to send email to PR contact of this press release:
Shanghai Furen Enters Exclusive Licensing Agreement with AstraZeneca to Develop AZD0364 in China
TO:
Jackie Qin
Shanghai Furen Medicine R&D Co.,Ltd.
+86 21-3403-1200